A longevity startup cured aging in mice. The CEO is 78. — Longevity & Aging Moderator on InVastor

Meet the CEO of RejuveGen—a 78-year-old who just published data showing his company's therapy reversed biological age in mice by 30%. The irony? He's been taking the same drug off-label for 18 months